Page last updated: 2024-11-12

cerberin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cerberin : A cardenolide glycoside that is the 2'-acetyl derivative of neriifolin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10031063
CHEMBL ID554969
CHEBI ID75049
SCHEMBL ID868106
MeSH IDM0049806

Synonyms (33)

Synonym
3-((2-o-acetyl-6-deoxy-3-o-methyl-alpha-l-glucopyranosyl)oxy)-14-hydroxycard-20(22)-endolide (3beta,5beta)-
3-((4-o-acetyl-6-deoxy-3-o-methyl-alpha-l-glucopyranosyl)oxy)-14-hydroxy-(3beta,5beta)-card-20(22)-enolide
5-beta-card-20(22)-enolide, 3-beta-((6-deoxy-3-o-methyl-beta-l-glucopyranosyl)oxy)-14-hydroxy-, 4'-acetate
card-20(22)-endolide, 3-((2-o-acetyl-6-deoxy-3-o-methyl-alpha-l-glucopyranosyl)oxy)-14-hydroxy-, (3beta,5beta)-
acetylneriifolin [german]
pveneniferin [german]
neriifolin-monoacetat [german]
cerberin
2'-acetylneriifolin
CHEMBL554969
chebi:75049 ,
C19984
3beta-o-(l-2'-o-acetylthevetosyl)-14beta-hydroxy-5beta-card-20(22)-enolide
(3beta,5beta)-3-[(2-o-acetyl-6-deoxy-3-o-methyl-alpha-l-glucopyranosyl)oxy]-14-hydroxycard-20(22)-enolide
acetylneriifolin
kw5a155s64 ,
25633-33-4
neriifolin-monoacetat
unii-kw5a155s64
pveneniferin
veneniferin
SCHEMBL868106
neriifolin 2'-acetate
neriifolin 2'-acetate [mi]
card-20(22)-enolide, 3-((2-o-acetyl-6-deoxy-3-o-methyl-.alpha.-l-glucopyranosyl)oxy)-14-hydroxy-, (3.beta.,5.beta.)-
monoacetylneriifolin
card-20(22)-enolide, 3-[(2-o-acetyl-6-deoxy-3-o-methyl-.alpha.-l-glucopyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta.)-
DTXSID30893922
Q5063899
3beta-o-(l-2'-o-acetyl thevetoyl)-14beta-hydroxy-5beta-card-20(22)-enolide
[(2r,3s,4r,5s,6s)-5-hydroxy-2-[[(3s,5r,8r,9s,10s,13r,14s,17r)-14-hydroxy-10,13-dimethyl-17-(5-oxo-2h-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyloxan-3-yl] acetate
[(2s,3s,4s,5s,6r)-5-hydroxy-6-[[(3s,5r,8r,9s,10s,13r,14s,17r)-14-hydroxy-10,13-dimethyl-17-(5-oxo-2h-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate
(3beta,5beta)-3-[(2-o-acetyl-6-deoxy-3-o-methyl-alpha-l-glucopyranosyl)oxy]-14-hydroxy-card-20(22)-enolide

Research Excerpts

Effects

ExcerptReferenceRelevance
"Cerberin has a mechanism of action similar to digoxin; hence, Cerbera odollam toxicity manifests similar to acute digoxin poisoning."( Cerbera odollam toxicity: A review.
Fatima, H; Fatima, TQ; Hussain, SA; Luis, SA; Madadin, M; Menezes, RG; Pasha, SB; Ram, P; Senthilkumaran, S; Siddiqi, TJ; Usman, MS, 2018
)
1.2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
cardenolide glycosideAny member of the class of cardenolides with glycosyl residues attached to position 3.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID421891Insecticidal activity against Ostrinia nubilalis2009Journal of natural products, Mar-27, Volume: 72, Issue:3
Plant seeds as sources of potential industrial chemicals, pharmaceuticals, and pest control agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.58 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (40.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]